OsseoLabs
Develops AI-driven personalized surgical implants using advanced 3D printing and proprietary porous architecture for maxillofacial, orthopedic, and cranial reconstruction.
- CEO / Founder
- Vikram Ahuja
- Team Size
- 11-50
- Stage
- Active
- Total Funding
- $4M
- Latest Round
- Grant
- Key Investors
- Texas Medical Center,Plug and Play Tech Center,MedTech Innovator,Finno Efra Accelerator,Program Management Unit for Competitiveness (PMUC)
Technology & Products
Key Products
AI-driven personalized 3D-printed orthopedic and craniomaxillofacial (CMF) implants, including the OsseoVision™ platform for automated surgical planning and OsseoMatrix™ porous architecture.
Technological Advantage
CLAIMED: Proprietary OsseoMatrix™ porous architecture with functionally graded porosity design mimicking natural bone; OsseoVision™ AI-based surgical planning platform with automated workflows; proprietary Two-step Topology Framework enabling design and material customization. VERIFIED (via surgeon testimonials): 30% reduction in operative time, faster patient recovery with earlier weight-bearing, 0% post-operative complication rate across 320+ cases.
Differentiation
Value Proposition
Patient-specific implants that improve surgical accuracy, reduce operating time, and enhance clinical outcomes through AI-driven surgical planning automation
How They Differentiate
AI-driven OsseoVision™ platform for automated surgical planning and personalized implant design; patented OsseoMatrix™ porous architecture optimizing bio-integration; proprietary Two-step Topology Framework enabling material customization; clinical validation showing 30% surgery time reduction and 0% complication rate.
Market & Competition
Target Customers
Hospitals, surgical centers, orthopedic and maxillofacial surgeons
Industry Verticals
Medical devices; Healthcare; Surgical services
Competitors
Meticuly, Bioventus, DePuy Synthes, Impulse Monitoring
Growth & Milestones
Growth Metrics
Established partnerships with over 20 hospitals in Thailand; Expanded into the US market in 2024 with partnerships across over 20 US hospitals; 170+ pilot surgeries in 35+ hospitals; 28 patents and 37 products; ISO13485-certified manufacturing; FDA & CE approvals targeted for Q4 2025
Major Milestones
Spin-off from KMUTT (King Mongkut's University of Technology Thonburi); developed patented TPMS© porous architecture for dental and orthopedic implants; obtained worldwide patent on TPMS© technology; quality policy certification for personalized mandible reconstruction plates and cutting guides; location: 126 Pracha Uthit Rd., Bang Mod, Thung Khru, Bangkok 10140
Notable Customers
["Faculty of Dentistry at Chulalongkorn University","Phramongkutklao Hospital (Department of Orthopedics)","Rajavithi Hospital","Ramathibodi Hospital"]